Spontaneous adverse event reports of Stevens–Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications

J Papay, N Yuen, G Powell… - … and drug safety, 2012 - Wiley Online Library
ABSTRACT Purpose Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) are medically serious skin reactions that are often drug induced. The mainstay of …

Identification of Stevens–Johnson syndrome and toxic epidermal necrolysis in electronic health record databases

RL Davis, MA Gallagher, MM Asgari… - … and drug safety, 2015 - Wiley Online Library
Abstract Background Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) carry a high mortality risk. While identifying clinical and genetic risk factors for these …

Incidence, causative factors and mortality rates of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT …

J Diphoorn, S Cazzaniga, C Gamba… - … and drug safety, 2016 - Wiley Online Library
Abstract Purpose Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)
are rare but severe cutaneous adverse drug reactions. We assessed incidence, drug …

Stevens–Johnson syndrome/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians regarding the risk?

C Haddad, A Sidoroff, SH Kardaun, M Mockenhaupt… - Drug safety, 2013 - Springer
Abstract Background Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are
severe drug reactions associated with high mortality and multiple incapacitating sequelae. In …

Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study

N Gronich, D Maman, N Stein, W Saliba - American Journal of Clinical …, 2022 - Springer
Objective Our objective was to describe the incidence of Stevens–Johnson syndrome/toxic
epidermal necrolysis (SJS/TEN) in a large unselected cohort, to validate the culprit drugs …

Validation of Stevens–Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink

N Frey, A Bircher, M Bodmer, SS Jick… - … and drug safety, 2017 - Wiley Online Library
Purpose To evaluate the validity of recorded diagnoses of Stevens–Johnson syndrome
(SJS) and toxic epidermal necrolysis (TEN) in the Clinical Practice Research Datalink …

Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention

MA Miliszewski, MG Kirchhof, S Sikora, A Papp… - The American journal of …, 2016 - Elsevier
Abstract Background Stevens-Johnson syndrome and toxic epidermal necrolysis are severe
mucocutaneous adverse drug reactions characterized by extensive epidermal detachment …

Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database

J Abe, R Umetsu, K Mataki, Y Kato, N Ueda… - … of pharmaceutical health …, 2016 - Springer
Abstract Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) are severe cutaneous adverse reactions associated with fatal disorders. Although …

[HTML][HTML] Stevens–Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

M Mockenhaupt, C Viboud, A Dunant, L Naldi… - Journal of Investigative …, 2008 - Elsevier
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe
cutaneous adverse reactions (SCAR) related to a variety of medications. They have a …

Medication use and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis

JC Roujeau, JP Kelly, L Naldi, B Rzany… - … England Journal of …, 1995 - Mass Medical Soc
Background Toxic epidermal necrolysis and Stevens–Johnson syndrome are rare, life-
threatening, drug-induced cutaneous reactions. We conducted a case–control study to …